A detailed history of Stanley Druckenmiller (Duquesne Family Office LLC) transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Duquesne Family Office LLC holds 1,021,367 shares of SWTX stock, worth $31.3 Million. This represents 1.32% of its overall portfolio holdings.

Number of Shares
1,021,367
Holding current value
$31.3 Million
% of portfolio
1.32%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$36.06 - $47.62 $36.8 Million - $48.6 Million
1,021,367 New
1,021,367 $38.5 Million

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $1.91B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track Stanley Druckenmiller's Portfolio

Track Stanley Druckenmiller Portfolio

Follow Stanley Druckenmiller (Duquesne Family Office LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duquesne Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Duquesne Family Office LLC and Stanley Druckenmiller with notifications on news.